Jump to Main Content
Precision Control of CRISPR-Cas9 Using Small Molecules and Light
- Gangopadhyay, Soumyashree A., Cox, Kurt J., Manna, Debasish, Lim, Donghyun, Maji, Basudeb, Zhou, Qingxuan, Choudhary, Amit
- Biochemistry 2019 v.58 no.4 pp. 234-244
- DNA, adaptive immunity, bacteria, biomedical research, biotechnology, chromatin, chromosome translocation, enzymes, epigenetics, gene editing, gene therapy, genes, genomics, genotoxicity, image analysis, loci, models
- The CRISPR (clustered regularly interspaced short palindromic repeat)-Cas system is an adaptive immune system of bacteria that has furnished several RNA-guided DNA endonucleases (e.g., Cas9) that are revolutionizing the field of genome engineering. Cas9 is being used to effect genomic alterations as well as in gene drives, where a particular trait may be propagated through a targeted species population over several generations. The ease of targeting catalytically impaired Cas9 to any genomic loci has led to development of technologies for base editing, chromatin imaging and modeling, epigenetic editing, and gene regulation. Unsurprisingly, Cas9 is being developed for numerous applications in biotechnology and biomedical research and as a gene therapy agent for multiple pathologies. There is a need for precise control of Cas9 activity over several dimensions, including those of dose, time, and space in these applications. Such precision controls, which are required of therapeutic agents, are particularly important for Cas9 as off-target effects, chromosomal translocations, immunogenic response, genotoxicity, and embryonic mosaicism are observed at elevated levels and with prolonged activity of Cas9. Here, we provide a perspective on advances in the precision control of Cas9 over aforementioned dimensions using external stimuli (e.g., small molecules or light) for controlled activation, inhibition, or degradation of Cas9.